These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15477219)

  • 41. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology.
    Cazzaniga G; Biondi A
    Haematologica; 2005 Mar; 90(3):382-90. PubMed ID: 15749670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.
    Szczepański T; Flohr T; van der Velden VH; Bartram CR; van Dongen JJ
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):37-57. PubMed ID: 11987915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Establishment of a real time quantitative-PCR assay for detection of TCR VgammaI-Jgamma gene rearrangement in acute lymphoblastic leukemia patients].
    Jiang XG; Xu B; Xu WJ; Li B
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):425-8. PubMed ID: 15355697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Zuna J; Hrusák O; Kalinová M; Muzíková K; Zörnerová T; Starý J; Trka J
    Vnitr Lek; 2000 Aug; 46(8):465-9. PubMed ID: 11048511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of TCR gamma gene in acute lymphoblastic leukemia after remission and its clinical significance].
    Liu L; Sun J; Yin H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):353-5. PubMed ID: 11189517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
    Sudhakar N; Nancy NK; Rajalekshmy KR; Ramanan G; Rajkumar T
    Am J Hematol; 2007 Mar; 82(3):215-21. PubMed ID: 17133429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Childhood T-cell acute lymphoblastic leukemia with four distinct immunophenotypes representing different stages of T-cell development.
    Miura T; Ouhira M; Koseki N; Obara Y; Fujimaki S; Imaizumi M; Kameoka J; Sasaki T; Funato T; Harigae H; Kaku M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):267-72. PubMed ID: 11400651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan.
    Imashuku S; Terui K; Matsuyama T; Asami K; Tsuchiya S; Ishii E; Kawa K; Kosaka Y; Eguchi H; Tsuchida M; Ikuta K; Kato S; Koizumi S; Okamura J; Morimoto A; Hibi S; Hamaoka K;
    Bone Marrow Transplant; 2003 Jun; 31(12):1127-35. PubMed ID: 12796792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.
    Ryan J; Quinn F; Meunier A; Boublikova L; Crampe M; Tewari P; O'Marcaigh A; Stallings R; Neat M; O'Meara A; Breatnach F; McCann S; Browne P; Smith O; Lawler M
    Br J Haematol; 2009 Jan; 144(1):107-15. PubMed ID: 19016726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dynamic analysis of junctional sequences of T cell receptor (TCR) delta and gamma gene rearrangement in childhood with acute lymphoblastic leukemia].
    Lu J; Gu R; Lei K; Wang X; Sun L; Pang X; Li X; Dong Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):301-4. PubMed ID: 11876997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relapse of biphenotypic leukemia confirmed by molecular study].
    Onozawa M; Hashino S; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Tanaka J; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Feb; 45(2):161-3. PubMed ID: 15045826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
    Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
    Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Precursor B-lymphoblastic transformation of grade I follicle center lymphoma.
    Kroft SH; Domiati-Saad R; Finn WG; Dawson DB; Schnitzer B; Singleton TP; Ross CW
    Am J Clin Pathol; 2000 Mar; 113(3):411-8. PubMed ID: 10705823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
    Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
    Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.
    Ouspenskaia MV; Johnston DA; Roberts WM; Estrov Z; Zipf TF
    Leukemia; 1995 Feb; 9(2):321-8. PubMed ID: 7869771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
    J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia.
    Robillard N; Cavé H; Méchinaud F; Guidal C; Garnache-Ottou F; Rohrlich PS; Avet-Loiseau H; Garand R
    Haematologica; 2005 Nov; 90(11):1516-23. PubMed ID: 16266899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.